Technologies Enabling Precision Medicine-based Drug Discovery

USD 950

* Required Fields

USD 950

PAY BY INVOICE

Be the first to review this product

This edition of the Drug Discovery TOE assesses the potential of drug discovery technologies that are enabling the era of precision medicine. Customization of microfluidic properties for the development of organ on a chip technologies are improving target identification and validations extensively.

The Drug Discovery TechVision Opportunity Engine (TOE) reports and analyzes about the latest developments in drug discovery and therapeutics, thereby providing an opportunity to acquire strategic insights into crucial developments in this industry domain. Technologies profiled include those used for biomarker and target discovery such as high throughput screening, signal transduction, micro array, RNAi, metabolomics, toxicogenomics, biosensors and nanotechnology. In addition to these, a fair focus shall be dedicated to the latest trends in therapeutic approaches across a diversity of diseases including infectious, genetic, metabolic, neurological, cardiac, and autoimmune disorders.

The Health and Wellness cluster tracks developments in a myriad of areas including genetic engineering, regenerative medicine, drug discovery and development, nanomedicine, nutrition, cosmetic procedures, pain and disease management and therapies, drug delivery, personalized medicine, and smart healthcare.

Keywords: Microfluidic system, humanization, kinase inhibition, single cell research, selective inhibition, target identification

Table of Contents

Technologies Enabling Precision Medicine-based Drug DiscoveryInnovations in the Pharma IndustryHumanizing Drug Discovery – Microphysiological SystemsCustom-made Microfluidic Systems – Single Cell ResearchPrecision Epitope Mapping Platform – Antibody ResearchEvidence-based Microbiome Modulators – Life Sciences ResearchExpediting New Drug Commercialization – Drug Discovery ResearchHigh Molecular Weight Compounds for Delivery–Drug Delivery ResearchExploiting Kinases for Treating Cancer–Oncology ResearchKey Patents and Industry InteractionsPatent AnalysisPatent Analysis (continued)Patent Analysis (continued)Industry InteractionsIndustry Interactions (continued)




Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.